Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À¯¹æ¾Ï ÀÏÂ÷Ä¡·á ÈÄ Á¶±â Àç¹ß: ÀÓ»óº´¸®ÇÐÀû ¹× ¿µ»óÀÇÇÐÀû ¿¹ÃøÀÎÀÚ ºÐ¼® Early Recurrence of Breast Cancer after the Primary Treatment: Analysis of Clinicopathological and Radiological Predictive Factors

´ëÇÑ¿µ»óÀÇÇÐȸÁö 2020³â 81±Ç 2È£ p.395 ~ 408
À±¼±±Ù, ¾È¿µÀÌ, ±è¼ºÇå, °­ºÀÁÖ,
¼Ò¼Ó »ó¼¼Á¤º¸
À±¼±±Ù ( Yun Sun-Geun ) 
Catholic University College of Medicine St. Vincent¡¯s Hospital Department of Radiology

¾È¿µÀÌ ( An Yeong-Yi ) 
Catholic University College of Medicine St. Vincent¡¯s Hospital Department of Radiology
±è¼ºÇå ( Kim Sung-Hun ) 
Catholic University College of Medicine Seoul St. Mary¡¯s Hospital Department of Radiology
°­ºÀÁÖ ( Kang Bong-Joo ) 
Catholic University College of Medicine Seoul St. Mary¡¯s Hospital Department of Radiology

Abstract

¸ñÀû: À¯¹æ¾Ï ÀÏÂ÷Ä¡·á ÈÄ Á¶±â Àç¹ß ¿¹Ãø¿¡ µµ¿òÀÌ µÇ´Â ÀÓ»óº´¸®ÇÐÀû ÀÎÀÚ ¹× ¿ø¹ß¾ÏÀÇ ¿µ»ó ÀÇÇÐÀû Ư¡À» ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù.

´ë»ó°ú ¹æ¹ý: º»¿ø¿¡¼­ 2010³â 1¿ùºÎÅÍ 2014³â 12¿ù±îÁö À¯¹æ º¸Á¸ ¼ö¼ú ¹× º¸Á¶¿ä¹ý Ä¡·á ÈÄ ÃßÀû°üÂûÀ» ¹ÞÀº 480¸íÀ» ´ë»óÀ¸·Î ÇÏ¿´´Ù. ÀÏÂ÷Ä¡·á ¿Ï°á ÈÄ 3³â À̳» Àç¹ßÇÑ °æ¿ì¸¦ Á¶±â Àç¹ßÀ¸·Î Á¤ÀÇÇÏ°í, ÀÌ¿Í °ü·ÃµÈ ÀÓ»óº´¸®ÇÐÀû ¹× ¿µ»óÀÇÇÐÀû ¿¹ÃøÀÎÀÚ¸¦ ¾Ë¾Æº¸±â À§ÇØ ´Üº¯·® ¹× ´Ùº¯·® ·ÎÁö½ºÆ½ ȸ±ÍºÐ¼®À» ½ÃÇàÇÏ¿´´Ù.

°á°ú: ´Üº¯·® ºÐ¼®¿¡¼­ ÀÓ»óº´¸®ÇÐÀû ÀÎÀÚ Áß ³ôÀº Á¾¾ç º´±â(p=0.021), °íµî±Þ Á¶Á÷ÇÐÀû ºÐÈ­µµ(p < 0.001), estrogen receptor ¼ö¿ëü À½¼º(p=0.002), Ki-67 °ú¹ßÇö(p=0.017), »ïÁßÀ½¼ºÀ¯¹æ ¾ÆÇü(p=0.019)°ú, ¿µ»ó ¼Ò°ß Áß À¯¹æ¾ÏÀÇ ´ÙÃÊÁ¡¼º(p < 0.001), µµÇ÷¯ °Ë»ç¿¡¼­ Å׵θ® Ç÷·ù(p=0.012), ÀÚ±â°ø¸í¿µ»ó¿¡¼­ Å׵θ® Á¶¿µÁõ°­(p < 0.001)ÀÌ Á¶±â Àç¹ß°ú À¯ÀÇÇÑ ¿¬°ü¼ºÀ» º¸¿´´Ù. ´Ùº¯·® ºÐ¼®¿¡¼­ ¿ø¹ß¾ÏÀÇ ³ôÀº Á¾¾ç º´±â[odds ratio (ÀÌÇÏ OR) = 3.47, 95% confidence interval (ÀÌÇÏ CI) 1.12~10.73, p=0.031]¿Í µµÇ÷¯ °Ë»ç¿¡¼­ Å׵θ® Ç÷·ù (OR = 3.32, 95% CI 1.38~8.02,p=0.008)°¡ Á¶±â Àç¹ß°ú °ü·ÃµÈ µ¶¸³ÀûÀÎ ¿¹ÃøÀÎÀÚ¿´´Ù.

°á·Ð: À¯¹æ¾Ï Ä¡·á Àü µµÇ÷¯ °Ë»ç¿¡¼­ ¿ø¹ß¾ÏÀÇ Å׵θ® Ç÷·ù ¼Ò°ßÀº À¯¹æ¾ÏÀÇ ÀÏÂ÷Ä¡·á ÈÄ Á¶±â Àç¹ßÀÇ µ¶¸³ÀûÀÎ ¿µ»óÀÇÇÐÀû ¿¹ÃøÀÎÀÚÀÌ´Ù.

Purpose: To evaluate the value of clinicopathologic factors and imaging features of primary breast cancer in predicting early recurrence after the primary treatment.

Materials and Methods: We enrolled 480 patients who had been followed-up after breast-conserving surgery and adjuvant therapy from January 2010 to December 2014 at our hospital. Early recurrence was defined as recurrence within 3 years after completion of primary treatment, and univariate and multivariate logistic regression analyses were performed to determine the clinicopathologic and imaging predictive factors of early recurrence.

Results: In the univariate analysis, among the clinicopathologic factors, advanced stage (p = 0.021), high histologic grade (p < 0.001), estrogen receptor negative (p = 0.002), high Ki-67 proliferation index (p = 0.017), and triple-negative breast cancer (p = 0.019), and among the imaging features, multifocality (p < 0.001), vessels in the rim on Doppler ultrasonography (US) (p = 0.012), and rim enhancement (p < 0.001) on magnetic resonance imaging of the breast were significantly associated with early recurrence. In the multivariate analysis, advanced stage [odds ratio (OR) = 3.47; 95% confidence interval (CI) 1.12?10.73; p = 0.031] and vessels in the rim on Doppler US (OR = 3.32; 95% CI 1.38?8.02; p = 0.008) were the independent predictive factors of early recurrence.

Conclusion: Vascular findings in the rim of the primary breast cancer on Doppler US before treatment is a radiologic independent predictive factor of early recurrence after the primary treatment.

Å°¿öµå

Breast Neoplasms; Ultrasonography; Doppler Ultrasound; Recurrence

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS